Literature DB >> 31107340

CORR Insights®: CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor- γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Stuart B Goodman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31107340      PMCID： PMC7000009          DOI： 10.1097/CORR.0000000000000789

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  7 in total

Review 1.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update.

Authors:  Michael A Mont; Jeffrey J Cherian; Rafael J Sierra; Lynne C Jones; Jay R Lieberman
Journal:  J Bone Joint Surg Am       Date:  2015-10-07       Impact factor: 5.284

2.  CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

3.  Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population.

Authors:  T-H Kim; J M Hong; B Oh; Y S Cho; J-Y Lee; H-L Kim; E-S Shin; J-E Lee; E K Park; S-Y Kim
Journal:  Osteoarthritis Cartilage       Date:  2008-03-18       Impact factor: 6.576

Review 4.  Osteonecrosis repair with bone marrow cell therapies: state of the clinical art.

Authors:  Philippe Hernigou; Charles-Henri Flouzat-Lachaniette; Jerome Delambre; Alexandre Poignard; Jerome Allain; Nathalie Chevallier; Helene Rouard
Journal:  Bone       Date:  2014-07-10       Impact factor: 4.398

Review 5.  Early-stage osteonecrosis of the femoral head: where are we and where are we going in year 2018?

Authors:  Eric Larson; Lynne C Jones; Stuart B Goodman; Kyung-Hoi Koo; Quanjun Cui
Journal:  Int Orthop       Date:  2018-04-04       Impact factor: 3.075

Review 6.  An evidence-based guide to the treatment of osteonecrosis of the femoral head.

Authors:  M Chughtai; N S Piuzzi; A Khlopas; L C Jones; S B Goodman; M A Mont
Journal:  Bone Joint J       Date:  2017-10       Impact factor: 5.082

7.  Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Isaac Guissou; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Hélène Rouard
Journal:  Int Orthop       Date:  2018-05-09       Impact factor: 3.075
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.